Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Area of Science:

• Oncology
• Gastroenterology
• Clinical Practice Guidelines

Background:

• Biliary tract cancers (BTCs), including gallbladder, intrahepatic, and extrahepatic cholangiocarcinoma, require standardized management strategies.
• The National Comprehensive Cancer Network (NCCN) convenes multidisciplinary expert panels to develop evidence-based guidelines.
• Regular updates ensure guidelines reflect the latest data on diagnosis and treatment.

Purpose of the Study:

• To present the NCCN Guidelines for the comprehensive care of patients with biliary tract cancers.
• To detail recommendations for adjuvant chemotherapy and chemoradiation for resectable BTCs.
• To outline systemic treatment options for patients with advanced or metastatic BTCs.

Main Methods:

• The NCCN Guidelines are developed through a consensus process involving a multidisciplinary panel of oncology experts.
• The panel reviews new research, clinical trial data, and treatment outcomes annually.
• Recommendations are based on the best available scientific evidence and expert clinical judgment.

Main Results:

• The guidelines provide specific recommendations for the evaluation and multidisciplinary management of BTCs.
• Adjuvant chemotherapy and chemoradiation strategies are outlined for resectable disease.
• Systemic therapy options, including targeted therapy and immunotherapy, are discussed for advanced BTCs.

Conclusions:

• The NCCN Guidelines offer a framework for optimal, evidence-based care for patients with biliary tract cancers.
• Adherence to these guidelines can improve patient outcomes through standardized and comprehensive treatment approaches.
• Ongoing evaluation of emerging therapies is crucial for advancing BTC management.